Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Washington Drug Letter > Teva Resolves 2009 Warning Letter for California Plant

Washington Drug Letter

Nov. 12, 2012 | Vol. 44 No. 45

Teva Resolves 2009 Warning Letter for California Plant

Teva Pharmaceuticals has resolved a long-outstanding warning letter for its Irvine, Calif., plant, the company said on its recent third-quarter earnings call.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Related Articles

Drugmakers’ Shortage Prevention Programs Coming Up Short: Survey Sandoz Subsidiary Warned for Specification Inspection Snafus Baxter Warned About Mold, GMP Deviations at Two Plants Drugmakers’ Shortage Prevention Programs Coming Up Short: Survey

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.